Among the T2DM-specific parameters, all factors showed significant reductions between admission and discharge, with the MetS(+) group exhibiting 1.2-fold greater changes in CRP (MetS(−): −21.8% ± 10.1 and MetS(+): −26.5% ± 7.9) and an 3.0-fold higher reduction in FBS (MetS(−): −4.4% ± 2.6 and MetS(+): −13.0% ± 2.4). This evidence concerns the gene CRP and metabolic syndrome.